Gastric Neuroendocrine Tumors - From Clinicopathologic to Immunophenotype Features
#1435
Introduction: Type 3 Gastric Neuroendocrine tumors (GNET3) natured in the absence of a specific gastric background of pathologic changes, while with poorer outcome due to a high rate of distant metastasis.
Aim(s): To investigate a potential effective therapy for GNET3.
Materials and methods: We retrospectively observed 16 cases of GNET3 treated in our hospital, including 12 surgical cases and 4 endoscopic submucosal dissection (ESD) cases from 2005 to 2014.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Ji Y, Xie Y, Sun Y, Wang H, Chen S,
Keywords: gastric, neuroendocrine tumor, mTOR,
To read the full abstract, please log into your ENETS Member account.